Business Of Biotech cover image

CAR T Therapy Cost Control With Laurence Cooper, M.D., Ph.D.

Business Of Biotech

00:00

The Sleeping Beauty System

The sleeping beauty system, this non-viral approach would sidestep a lot of the current issues that folks were facing when they were using viral based manufacture. One and a half million Americans every year have an invasive cancer or solid tumor. How are we going to get to that point if we're stuck using viruses? A DNA plasmid cuts all of that out. You don't need to do any incubation or any propagation in tissue culture. That really allows for these economies of scale that get at the numbers that we want to treat.

Play episode from 12:33
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app